Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroprotective effects of palmitoylethanolamide in diabetic neuropathy: a pilot study
2009-013643-11Phase 2Completed
- Sponsor
- Carlo Besta Neurological Institute
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of palmitoylethanolamide in diabetic polyneuropathy (DPN), sponsored by Carlo Besta Neurological Institute. Primary endpoint: intraepidermal nerve fibre (IENF) density at distal leg. Started Jul 2009; status: completed.
02
Drugs
palmitoylethanolamide
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on 2009-013643-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013643-11.